首页> 外文期刊>Urologic oncology >A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer.
【24h】

A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer.

机译:除局部晚期前列腺癌放疗外,还长期服用戈舍瑞林辅助治疗的成本结果分析。

获取原文
获取原文并翻译 | 示例
           

摘要

To quantify the incremental costs and outcomes of using long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer. The cost of radiotherapy for prostate cancer has been calculated using an activity-costing model. The total cost of administering adjuvant hormonal therapy for 3 years is based on local pharmacy charges plus typical physician billing fees and additional laboratory costs. Outcome data were obtained from the published EORTC 22,863 randomized trial comparing treatment of locally advanced prostate cancer with radiotherapy alone or in combination with 3 years of adjuvant goserelin. Using this information, the cost-effectiveness of adjuvant goserelin was calculated and expressed in terms of dollars per life-years (LY) gained. The total institutional costs of radiotherapy are
机译:为了量化局部放疗和前列腺癌放疗之外使用长期辅助戈舍瑞林的增量成本和结果。前列腺癌放射治疗的费用已经使用活动成本模型进行了计算。进行3年激素辅助治疗的总费用是根据当地药房费用加上典型的医生账单费用和额外的实验室费用得出的。结果数据来自已发表的EORTC 22,863随机试验,该试验比较了局部放疗与单独放疗或联合3年辅助戈舍瑞林治疗的局部晚期前列腺癌。利用这些信息,计算了戈舍瑞林辅助剂的成本效益,并以每生命年(LY)的美元数表示。放疗的机构总费用为

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号